Advertisement

Ads Placeholder
Loading...

Lonza Group AG

LZAGF•PNK
Healthcare
Medical - Diagnostics & Research
$647.25
$-3.04(-0.47%)
U.S. Market opens in 56h 19m

Lonza Group AG (LZAGF) Stock Overview

Explore Lonza Group AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap45.4B
P/E Ratio39.98
EPS (TTM)$16.26
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$601.35
3 Months$737.93
1 Year Target$627.05

LZAGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lonza Group AG (LZAGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $627.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.98 and a market capitalization of 45.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.47%
5-Day Change
7.57%
1-Month Change
-3.57%
3-Month Change
-5.53%
6-Month Change
-7.54%
Year-to-Date (YTD) Change
-5.53%
1-Year Change
0.43%
3-Year Change
7.93%
5-Year Change
10.50%
All-Time (Max) Change
1248.44%

Contact Information

https://www.lonza.com
41 61 316 81 11
Muenchensteinerstrasse 38, Basel, NaN, 4002

Company Facts

179,950 Employees
IPO DateFeb 13, 2009
CountryCH
Actively Trading

Frequently Asked Questions